196 related articles for article (PubMed ID: 21431944)
21. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
22. Relative expression and correlation of tumor necrosis factor-α, interferon-γ, and interleukin-17 in the rheumatoid synovium.
Nakajima A; Aoki Y; Sonobe M; Watanabe F; Takahashi H; Saito M; Nakagawa K
Clin Rheumatol; 2016 Jul; 35(7):1691-7. PubMed ID: 27038187
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
24. Elevated Levels of Soluble ST2 were Associated with Rheumatoid Arthritis Disease Activity and Ameliorated Inflammation in Synovial Fibroblasts.
Shi LJ; Liu C; Li JH; Zhu XY; Li YN; Li JT
Chin Med J (Engl); 2018 Feb; 131(3):316-322. PubMed ID: 29363647
[TBL] [Abstract][Full Text] [Related]
25. Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-α.
Ren J; Feng Z; Lv Z; Chen X; Li J
J Rheumatol; 2011 Oct; 38(10):2112-8. PubMed ID: 21765110
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.
Lee A; Qiao Y; Grigoriev G; Chen J; Park-Min KH; Park SH; Ivashkiv LB; Kalliolias GD
Arthritis Rheum; 2013 Apr; 65(4):928-38. PubMed ID: 23335080
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis.
Badot V; Galant C; Nzeusseu Toukap A; Theate I; Maudoux AL; Van den Eynde BJ; Durez P; Houssiau FA; Lauwerys BR
Arthritis Res Ther; 2009; 11(2):R57. PubMed ID: 19389237
[TBL] [Abstract][Full Text] [Related]
28. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis.
Alsaleh G; Sparsa L; Chatelus E; Ehlinger M; Gottenberg JE; Wachsmann D; Sibilia J
Arthritis Res Ther; 2010; 12(4):R135. PubMed ID: 20615213
[TBL] [Abstract][Full Text] [Related]
29. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy.
Wright HL; Bucknall RC; Moots RJ; Edwards SW
Rheumatology (Oxford); 2012 Mar; 51(3):451-9. PubMed ID: 22179732
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint.
Yeremenko N; Zwerina K; Rigter G; Pots D; Fonseca JE; Zwerina J; Schett G; Baeten D
Arthritis Rheumatol; 2015 May; 67(8):2071-5. PubMed ID: 25941031
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis.
Šenolt L; Prajzlerová K; Hulejová H; Šumová B; Filková M; Veigl D; Pavelka K; Vencovský J
Cytokine; 2017 Sep; 97():187-192. PubMed ID: 28662439
[TBL] [Abstract][Full Text] [Related]
32. Gastrodia elata attenuates inflammatory response by inhibiting the NF-κB pathway in rheumatoid arthritis fibroblast-like synoviocytes.
Li Y; Wang LM; Xu JZ; Tian K; Gu CX; Li ZF
Biomed Pharmacother; 2017 Jan; 85():177-181. PubMed ID: 27936399
[TBL] [Abstract][Full Text] [Related]
33. Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation.
Umar S; Hedaya O; Singh AK; Ahmed S
Toxicol Appl Pharmacol; 2015 Sep; 287(3):299-305. PubMed ID: 26134265
[TBL] [Abstract][Full Text] [Related]
34. A pro-inflammatory role for A20 and ABIN family proteins in human fibroblast-like synoviocytes in rheumatoid arthritis.
Igarashi H; Yahagi A; Saika T; Hashimoto J; Tomita T; Yoshikawa H; Ishihara K
Immunol Lett; 2012 Jan; 141(2):246-53. PubMed ID: 22093807
[TBL] [Abstract][Full Text] [Related]
35. IL-33 regulates TNF-α dependent effects in synovial fibroblasts.
Kunisch E; Chakilam S; Gandesiri M; Kinne RW
Int J Mol Med; 2012 Apr; 29(4):530-40. PubMed ID: 22246057
[TBL] [Abstract][Full Text] [Related]
36. Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis.
Chen DP; Wong CK; Tam LS; Li EK; Lam CW
Cell Mol Immunol; 2011 Nov; 8(6):469-78. PubMed ID: 21946433
[TBL] [Abstract][Full Text] [Related]
37. Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts.
Yoshida S; Katoh T; Tetsuka T; Uno K; Matsui N; Okamoto T
J Immunol; 1999 Jul; 163(1):351-8. PubMed ID: 10384135
[TBL] [Abstract][Full Text] [Related]
38. Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis.
Hong YS; Moon SJ; Joo YB; Jeon CH; Cho ML; Ju JH; Oh HJ; Heo YJ; Park SH; Kim HY; Min JK
J Korean Med Sci; 2011 Sep; 26(9):1132-9. PubMed ID: 21935266
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients.
Chemel M; Le Goff B; Brion R; Cozic C; Berreur M; Amiaud J; Bougras G; Touchais S; Blanchard F; Heymann MF; Berthelot JM; Verrecchia F; Heymann D
Ann Rheum Dis; 2012 Jan; 71(1):150-4. PubMed ID: 22039170
[TBL] [Abstract][Full Text] [Related]
40. High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts.
Wähämaa H; Schierbeck H; Hreggvidsdottir HS; Palmblad K; Aveberger AC; Andersson U; Harris HE
Arthritis Res Ther; 2011 Aug; 13(4):R136. PubMed ID: 21871094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
